Patel Tushar Bhikhubhai 13D and 13G filings for Amneal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-17 4:45 pm Sale | 2025-03-14 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 48,578,209 15.700% | -5,000,000 (-9.33%) | Filing |
| 2024-05-13 4:15 pm Unchanged | 2024-05-09 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 53,578,209 17.400% | 0 (Unchanged) | Filing |
| 2023-11-08 4:55 pm Unchanged | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 53,578,209 17.500% | 0 (Unchanged) | Filing |
| 2023-10-17 7:27 pm Unchanged | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 53,578,209 25.800% | 0 (Unchanged) | Filing |